655 related articles for article (PubMed ID: 17727795)
1. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
2. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
3. In-vitro investigation regarding the effects of Gelucire
Dubray O; Jannin V; Demarne F; Pellequer Y; Lamprecht A; Béduneau A
Int J Pharm; 2016 Dec; 515(1-2):293-299. PubMed ID: 27720954
[TBL] [Abstract][Full Text] [Related]
4. Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells.
Jia JX; Wasan KM
J Pharm Pharm Sci; 2008; 11(3):45-62. PubMed ID: 18801307
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?
Collett A; Tanianis-Hughes J; Warhurst G
Biochem Pharmacol; 2004 Aug; 68(4):783-90. PubMed ID: 15276086
[TBL] [Abstract][Full Text] [Related]
6. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
Shen Q; Lin Y; Handa T; Doi M; Sugie M; Wakayama K; Okada N; Fujita T; Yamamoto A
Int J Pharm; 2006 Apr; 313(1-2):49-56. PubMed ID: 16500056
[TBL] [Abstract][Full Text] [Related]
7. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
8. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
Xiao JJ; Foraker AB; Swaan PW; Liu S; Huang Y; Dai Z; Chen J; Sadée W; Byrd J; Marcucci G; Chan KK
J Pharmacol Exp Ther; 2005 Apr; 313(1):268-76. PubMed ID: 15634944
[TBL] [Abstract][Full Text] [Related]
9. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
10. Impact of P-glycoprotein on clopidogrel absorption.
Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
[TBL] [Abstract][Full Text] [Related]
11. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
[TBL] [Abstract][Full Text] [Related]
12. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
Wang XD; Meng MX; Gao LB; Liu T; Xu Q; Zeng S
Int J Pharm; 2009 Aug; 378(1-2):1-8. PubMed ID: 19465099
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.
Batrakova EV; Li S; Vinogradov SV; Alakhov VY; Miller DW; Kabanov AV
J Pharmacol Exp Ther; 2001 Nov; 299(2):483-93. PubMed ID: 11602658
[TBL] [Abstract][Full Text] [Related]
14. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
15. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.
de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC
Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
[TBL] [Abstract][Full Text] [Related]
17. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
18. Potential role for human P-glycoprotein in the transport of lacosamide.
Zhang C; Chanteux H; Zuo Z; Kwan P; Baum L
Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
[TBL] [Abstract][Full Text] [Related]
19. Potential mechanisms by which Peceol increases the gastrointestinal absorption of amphotericin B.
Risovic V; Sachs-Barrable K; Boyd M; Wasan KM
Drug Dev Ind Pharm; 2004 Aug; 30(7):767-74. PubMed ID: 15491054
[TBL] [Abstract][Full Text] [Related]
20. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]